chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications information was reported. No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-051356 (Patient Link).
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: Maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 30-Aug-2020 and the estimated date of delivery was 06-Jun-2021. On 18-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-eighth week of the pregnancy.  On 18-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Sep-2020, Pregnancy test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported
Age: 16.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient under 18 years of age, got the Covid19 Vaccine Moderna; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient under 18 years of age, got the Covid19 Vaccine Moderna) in a 16-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient under 18 years of age, got the Covid19 Vaccine Moderna). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient under 18 years of age, got the Covid19 Vaccine Moderna) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was reported.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Appetite disorder, Chills, Diarrhoea, Dizziness, Migraine
Clinical narrative: diarrhea daily; appetite is erratic; dizzy; nauseous; migraine headache; shaking; chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of TREMOR (shaking), MIGRAINE (migraine headache), DIARRHOEA (diarrhea daily), APPETITE DISORDER (appetite is erratic) and DIZZINESS (dizzy) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ATORVASTATIN, DILTIAZEM, HYDRALAZINE, LEVOTHYROXINE, LISINOPRIL, METOPROLOL, RIVAROXABAN (XARELTO), GLIPIZIDE, SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]) and MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced TREMOR (shaking) and CHILLS (chills). On 28-Feb-2021, the patient experienced MIGRAINE (migraine headache), DIZZINESS (dizzy) and NAUSEA (nauseous). On 19-Mar-2021, the patient experienced DIARRHOEA (diarrhea daily) and APPETITE DISORDER (appetite is erratic). At the time of the report, TREMOR (shaking), MIGRAINE (migraine headache), DIARRHOEA (diarrhea daily), APPETITE DISORDER (appetite is erratic), DIZZINESS (dizzy), NAUSEA (nauseous) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was provided
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Tremor
Clinical narrative: diarrhea daily; appetite is erratic; dizzy; nauseous; migraine headache; shaking; chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of TREMOR (shaking), MIGRAINE (migraine headache), DIARRHOEA (diarrhea daily), APPETITE DISORDER (appetite is erratic) and DIZZINESS (dizzy) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ATORVASTATIN, DILTIAZEM, HYDRALAZINE, LEVOTHYROXINE, LISINOPRIL, METOPROLOL, RIVAROXABAN (XARELTO), GLIPIZIDE, SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]) and MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced TREMOR (shaking) and CHILLS (chills). On 28-Feb-2021, the patient experienced MIGRAINE (migraine headache), DIZZINESS (dizzy) and NAUSEA (nauseous). On 19-Mar-2021, the patient experienced DIARRHOEA (diarrhea daily) and APPETITE DISORDER (appetite is erratic). At the time of the report, TREMOR (shaking), MIGRAINE (migraine headache), DIARRHOEA (diarrhea daily), APPETITE DISORDER (appetite is erratic), DIZZINESS (dizzy), NAUSEA (nauseous) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was provided
Sex: F
Vaccine: COVID19, UNK
Symptoms: Chills, Feeling hot, Hot flush, Myalgia, Swelling
Clinical narrative: hot flashes; hot under arm; swollen under arm with Humira; chills; hard at injection site; swollen at injection site; red at injection site; body aches/muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (hot flashes), FEELING HOT (hot under arm), SWELLING (swollen under arm with Humira), CHILLS (chills) and MYALGIA (body aches/muscle aches) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Crohn's disease.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced HOT FLUSH (hot flashes), FEELING HOT (hot under arm), SWELLING (swollen under arm with Humira), CHILLS (chills), MYALGIA (body aches/muscle aches), VACCINATION SITE INDURATION (hard at injection site), VACCINATION SITE SWELLING (swollen at injection site) and VACCINATION SITE ERYTHEMA (red at injection site). At the time of the report, HOT FLUSH (hot flashes), FEELING HOT (hot under arm), SWELLING (swollen under arm with Humira), CHILLS (chills), MYALGIA (body aches/muscle aches), VACCINATION SITE INDURATION (hard at injection site), VACCINATION SITE SWELLING (swollen at injection site) and VACCINATION SITE ERYTHEMA (red at injection site) had resolved.            Concomitant medication and treatment drug were not reported.
Sex: F
Vaccine: COVID19, UNK
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site swelling
Clinical narrative: hot flashes; hot under arm; swollen under arm with Humira; chills; hard at injection site; swollen at injection site; red at injection site; body aches/muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (hot flashes), FEELING HOT (hot under arm), SWELLING (swollen under arm with Humira), CHILLS (chills) and MYALGIA (body aches/muscle aches) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Crohn's disease.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced HOT FLUSH (hot flashes), FEELING HOT (hot under arm), SWELLING (swollen under arm with Humira), CHILLS (chills), MYALGIA (body aches/muscle aches), VACCINATION SITE INDURATION (hard at injection site), VACCINATION SITE SWELLING (swollen at injection site) and VACCINATION SITE ERYTHEMA (red at injection site). At the time of the report, HOT FLUSH (hot flashes), FEELING HOT (hot under arm), SWELLING (swollen under arm with Humira), CHILLS (chills), MYALGIA (body aches/muscle aches), VACCINATION SITE INDURATION (hard at injection site), VACCINATION SITE SWELLING (swollen at injection site) and VACCINATION SITE ERYTHEMA (red at injection site) had resolved.            Concomitant medication and treatment drug were not reported.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain in extremity
Clinical narrative: sore arm; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), CHILLS (chills) and FATIGUE (fatigue) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 029L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm), CHILLS (chills) and FATIGUE (fatigue). At the time of the report, PAIN IN EXTREMITY (sore arm), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.            Concomitant medication and treatment information were not reported.  Action taken with mRNA-1273 in response to the event was Not Applicable   This case was linked to MOD-2021-051329, MOD-2021-051329 (Patient Link).
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: rash in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash in the injection site) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and CYANOCOBALAMIN (VITAMIN B 12 [CYANOCOBALAMIN]) for an unknown indication.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced VACCINATION SITE RASH (rash in the injection site). At the time of the report, VACCINATION SITE RASH (rash in the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication included diabetes medication. No treatment medications provided
Age: 70.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Feeling abnormal, Malaise, Nausea, Somnolence, Vomiting
Clinical narrative: feel heavy, like brain fog; felt terrible/still feels very not good/feels crappy; felt like would vomit again; really very sleepy; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feel heavy, like brain fog), SOMNOLENCE (really very sleepy), MALAISE (felt terrible/still feels very not good/feels crappy), NAUSEA (felt like would vomit again) and VOMITING (vomiting) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RIMEGEPANT SULFATE (NURTEC ODT) tablet for Migraine.    Concurrent medical conditions included Thyroid disorder and Migraine since 1963.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021 at 7:00 AM, the patient started RIMEGEPANT SULFATE (NURTEC ODT) (Sublingual) 75 milligram. On 18-Feb-2021 at 8:30 AM, the patient experienced VOMITING (vomiting). On 18-Feb-2021 at 9:15 AM, the patient experienced SOMNOLENCE (really very sleepy). On 18-Feb-2021 at 9:35 AM, the patient experienced NAUSEA (felt like would vomit again). On 18-Feb-2021 at 9:45 AM, the patient experienced FEELING ABNORMAL (feel heavy, like brain fog) and MALAISE (felt terrible/still feels very not good/feels crappy). At the time of the report, FEELING ABNORMAL (feel heavy, like brain fog), SOMNOLENCE (really very sleepy), MALAISE (felt terrible/still feels very not good/feels crappy), NAUSEA (felt like would vomit again) and VOMITING (vomiting) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: White blood cell count, White blood cell count increased
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of WHITE BLOOD CELL COUNT INCREASED (white blood cell count went up) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WHITE BLOOD CELL COUNT INCREASED (white blood cell count went up). At the time of the report, WHITE BLOOD CELL COUNT INCREASED (white blood cell count went up) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, White blood cell count: (High) went up.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided . No treatment details were provided .
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Gait inability, Vaccination complication
Clinical narrative: fallen 5 times since 2/17; has gone from using a walker to being wheelchair bound; 2nd Moderna dose packs a wallop; This spontaneous case was reported by a patient family member or friend and describes the occurrence of FALL (fallen 5 times since 2/17), GAIT INABILITY (has gone from using a walker to being wheelchair bound) and VACCINATION COMPLICATION (2nd Moderna dose packs a wallop) in a 93-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FALL (fallen 5 times since 2/17), GAIT INABILITY (has gone from using a walker to being wheelchair bound) and VACCINATION COMPLICATION (2nd Moderna dose packs a wallop). At the time of the report, FALL (fallen 5 times since 2/17), GAIT INABILITY (has gone from using a walker to being wheelchair bound) and VACCINATION COMPLICATION (2nd Moderna dose packs a wallop) outcome was unknown.            No concomitant medications or treatment medications were reported Action taken with mRNA-1273 in response to the event was not applicable
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Oropharyngeal pain, Pruritus, Rash
Clinical narrative: internal itching; extreme body warmth; rash in midsection of torso and neck; severe sore throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (severe sore throat), PRURITUS (internal itching), FEELING HOT (extreme body warmth) and RASH (rash in midsection of torso and neck) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (severe sore throat) and RASH (rash in midsection of torso and neck). On an unknown date, the patient experienced PRURITUS (internal itching) and FEELING HOT (extreme body warmth). At the time of the report, OROPHARYNGEAL PAIN (severe sore throat), PRURITUS (internal itching), FEELING HOT (extreme body warmth) and RASH (rash in midsection of torso and neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (hives). At the time of the report, URTICARIA (hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details not provided.  concomitant details not provided.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Head injury, Tremor
Clinical narrative: extremely shaking so severe; collapse on the floor; impacted his head and cracked; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (extremely shaking so severe), FALL (collapse on the floor) and HEAD INJURY (impacted his head and cracked) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included METFORMIN, DUPILUMAB (DUPIXENT) and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TREMOR (extremely shaking so severe), FALL (collapse on the floor) and HEAD INJURY (impacted his head and cracked). At the time of the report, TREMOR (extremely shaking so severe), FALL (collapse on the floor) and HEAD INJURY (impacted his head and cracked) outcome was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (slightly sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 041L20A) for COVID-19 vaccination. No medical history reported. On 04-Feb-2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced pain in extremity (slightly sore arm). At the time of the report, pain in extremity (slightly sore arm) resolved. mRNA-1273 (Moderna COVID-19 vaccine), unknown dosing remained unchanged. The reporter did not provide any causality assessment, concomitant product use, treatment information or lab details. This case linked to MOD-2021-051409 (patient link).
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Somnolence
Clinical narrative: Sleepy; She feel very tired; Nano second headache; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Sleepy), FATIGUE (She feel very tired) and HEADACHE (Nano second headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 004M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced SOMNOLENCE (Sleepy), FATIGUE (She feel very tired) and HEADACHE (Nano second headache). At the time of the report, SOMNOLENCE (Sleepy), FATIGUE (She feel very tired) and HEADACHE (Nano second headache) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  Patient took 1st day after the 1st dose aspirin.  Patient received a lot of concomitant medication.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Illness, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very sick, worst sickness), CHILLS (feel extremely chilly), HEADACHE (feeling headache) and PYREXIA (fever of 103.4) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced ILLNESS (very sick, worst sickness), CHILLS (feel extremely chilly) and PYREXIA (fever of 103.4). On 26-Feb-2021, the patient experienced HEADACHE (feeling headache). At the time of the report, ILLNESS (very sick, worst sickness), CHILLS (feel extremely chilly), HEADACHE (feeling headache) and PYREXIA (fever of 103.4) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 103.4 (High) 103.4. No concomitant medications reported by reporter. Treatment medication not reported. Action taken with mRNA-1273 was not applicable. Reporter did not allow further contact.
Sex: U
Vaccine: COVID19
Symptoms: Dehydration, Diarrhoea, Fatigue, Pain in extremity
Clinical narrative: tired; explosive diarrhea; slightly sore arm; maybe I was dehydrated; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (explosive diarrhea), PAIN IN EXTREMITY (slightly sore arm), DEHYDRATION (maybe I was dehydrated) and FATIGUE (tired) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 041L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced DIARRHOEA (explosive diarrhea) and PAIN IN EXTREMITY (slightly sore arm). On 05-Mar-2021, the patient experienced FATIGUE (tired). In March 2021, the patient experienced DEHYDRATION (maybe I was dehydrated). At the time of the report, DIARRHOEA (explosive diarrhea) had resolved and PAIN IN EXTREMITY (slightly sore arm), DEHYDRATION (maybe I was dehydrated) and FATIGUE (tired) outcome was unknown.            This case was linked to MOD-2021-051406.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Somnolence
Clinical narrative: quite sick; slept for 12 hours; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (quite sick) and SOMNOLENCE (slept for 12 hours) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (quite sick) and SOMNOLENCE (slept for 12 hours). At the time of the report, ILLNESS (quite sick) and SOMNOLENCE (slept for 12 hours) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Headache
Clinical narrative: headache; REDNESS; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and ERYTHEMA (REDNESS) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced ERYTHEMA (REDNESS). On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) and ERYTHEMA (REDNESS) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant details were provided. No treatment details were provided. Consent given for safety to contact patient. Consent not obtained for her HCP.   Reporter did not allow further contact
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Tingling of the arms and legs; This spontaneous case was reported by a pharmacist and describes the occurrence of PARAESTHESIA (Tingling of the arms and legs) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced PARAESTHESIA (Tingling of the arms and legs). At the time of the report, PARAESTHESIA (Tingling of the arms and legs) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medication was reported.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Vaccination site swelling, Vaccination site warmth
Clinical narrative: swelling; warmth; cold symptoms; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold symptoms), VACCINATION SITE SWELLING (swelling) and VACCINATION SITE WARMTH (warmth) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001b21a) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced NASOPHARYNGITIS (cold symptoms). On 18-Mar-2021, the patient experienced VACCINATION SITE SWELLING (swelling) and VACCINATION SITE WARMTH (warmth). At the time of the report, NASOPHARYNGITIS (cold symptoms), VACCINATION SITE SWELLING (swelling) and VACCINATION SITE WARMTH (warmth) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter.  Treatment information was not provided. Lab details were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow-up received contains no new information.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Myalgia, Nausea
Clinical narrative: Dizziness/Light headed; Arm pain; Body ache; Chills; headache; Nausea; This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (Dizziness/Light headed), PAIN IN EXTREMITY (Arm pain), MYALGIA (Body ache), CHILLS (Chills) and HEADACHE (headache) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness/Light headed), PAIN IN EXTREMITY (Arm pain), MYALGIA (Body ache), CHILLS (Chills), HEADACHE (headache) and NAUSEA (Nausea). At the time of the report, DIZZINESS (Dizziness/Light headed), PAIN IN EXTREMITY (Arm pain), MYALGIA (Body ache), CHILLS (Chills), HEADACHE (headache) and NAUSEA (Nausea) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were provided
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Dizziness/Light headed; Arm pain; Body ache; Chills; headache; Nausea; This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (Dizziness/Light headed), PAIN IN EXTREMITY (Arm pain), MYALGIA (Body ache), CHILLS (Chills) and HEADACHE (headache) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness/Light headed), PAIN IN EXTREMITY (Arm pain), MYALGIA (Body ache), CHILLS (Chills), HEADACHE (headache) and NAUSEA (Nausea). At the time of the report, DIZZINESS (Dizziness/Light headed), PAIN IN EXTREMITY (Arm pain), MYALGIA (Body ache), CHILLS (Chills), HEADACHE (headache) and NAUSEA (Nausea) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were provided
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood pressure measurement, Fatigue, Feeling abnormal, Headache
Clinical narrative: leg pain from calve down to ankle; felt badly; Headache; fatigue; arm soreness from second shot; pain in shoulders; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness from second shot), FEELING ABNORMAL (felt badly), ARTHRALGIA (leg pain from calve down to ankle), ARTHRALGIA (pain in shoulders) and HEADACHE (Headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), ALPRAZOLAM (XANAX) and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm soreness from second shot) and ARTHRALGIA (pain in shoulders). On 18-Mar-2021, the patient experienced FEELING ABNORMAL (felt badly), HEADACHE (Headache) and FATIGUE (fatigue). On an unknown date, the patient experienced ARTHRALGIA (leg pain from calve down to ankle). On 18-Mar-2021, ARTHRALGIA (pain in shoulders) had resolved. On 19-Mar-2021, FEELING ABNORMAL (felt badly) and FATIGUE (fatigue) had resolved. At the time of the report, PAIN IN EXTREMITY (arm soreness from second shot) and ARTHRALGIA (leg pain from calve down to ankle) outcome was unknown and HEADACHE (Headache) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Mar-2021, Blood pressure measurement: 98/56 Low. On 19-Mar-2021, Heart rate: 99 Low. On an unknown date, Blood pressure measurement: 82/57 Low.         The action taken with mRNA-1273(Moderna COVID-19 vaccine) was not applicable. No treatment drugs were reported  .
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Pain in extremity
Clinical narrative: leg pain from calve down to ankle; felt badly; Headache; fatigue; arm soreness from second shot; pain in shoulders; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness from second shot), FEELING ABNORMAL (felt badly), ARTHRALGIA (leg pain from calve down to ankle), ARTHRALGIA (pain in shoulders) and HEADACHE (Headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), ALPRAZOLAM (XANAX) and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm soreness from second shot) and ARTHRALGIA (pain in shoulders). On 18-Mar-2021, the patient experienced FEELING ABNORMAL (felt badly), HEADACHE (Headache) and FATIGUE (fatigue). On an unknown date, the patient experienced ARTHRALGIA (leg pain from calve down to ankle). On 18-Mar-2021, ARTHRALGIA (pain in shoulders) had resolved. On 19-Mar-2021, FEELING ABNORMAL (felt badly) and FATIGUE (fatigue) had resolved. At the time of the report, PAIN IN EXTREMITY (arm soreness from second shot) and ARTHRALGIA (leg pain from calve down to ankle) outcome was unknown and HEADACHE (Headache) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Mar-2021, Blood pressure measurement: 98/56 Low. On 19-Mar-2021, Heart rate: 99 Low. On an unknown date, Blood pressure measurement: 82/57 Low.         The action taken with mRNA-1273(Moderna COVID-19 vaccine) was not applicable. No treatment drugs were reported  .
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Vaccination site bruising, Vaccination site haemorrhage, Vaccination site pain, Vaccination site swelling
Clinical narrative: Bruise at the injection site; bump at the injection site; blood at the injection site on the cotton ball; didn't feel well overall; Sore arm which got worse over the evening; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (blood at the injection site on the cotton ball), VACCINATION SITE BRUISING (Bruise at the injection site), MALAISE (didn't feel well overall), VACCINATION SITE PAIN (Sore arm which got worse over the evening) and VACCINATION SITE SWELLING (bump at the injection site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure fluctuation.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (blood at the injection site on the cotton ball), MALAISE (didn't feel well overall) and VACCINATION SITE PAIN (Sore arm which got worse over the evening). On 10-Mar-2021, the patient experienced VACCINATION SITE BRUISING (Bruise at the injection site) and VACCINATION SITE SWELLING (bump at the injection site). On 10-Mar-2021, VACCINATION SITE HAEMORRHAGE (blood at the injection site on the cotton ball), MALAISE (didn't feel well overall) and VACCINATION SITE PAIN (Sore arm which got worse over the evening) had resolved. At the time of the report, VACCINATION SITE BRUISING (Bruise at the injection site) and VACCINATION SITE SWELLING (bump at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products included Blood pressure medicine. No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Additional information received: Updated event outcome from  unknown to recovered for events "Bruise and bump at the injection site". Patient had declined further follow-up.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), ALPRAZOLAM (XANAX) and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm soreness). On 18-Feb-2021, PAIN IN EXTREMITY (arm soreness) had resolved. Not Provided          No treatment information was provided.   This case was linked to MOD-2021-051416 (Patient Link).
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle tightness, Muscular weakness, Vaccination site discomfort, Vaccination site erythema, Vaccination site pain
Clinical narrative: Arm weakness; Covid arm ring; Redness; Arm achy/arm tenderness; Arm inflammation; Muscle tension; Arm uncomfortable/arm didn't feel great; Arm on fire; Large big red circle about three inches/big circle on arm; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TIGHTNESS (Muscle tension), VACCINATION SITE DISCOMFORT (Arm uncomfortable/arm didn't feel great), MUSCULAR WEAKNESS (Arm weakness), VACCINATION SITE REACTION (Covid arm ring) and VACCINATION SITE WARMTH (Arm on fire) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.  Concomitant products included COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), VITAMIN B [VITAMIN B NOS], VITAMIN C [ASCORBIC ACID], CALCIUM, UBIDECARENONE (QUNOL LIQUID COQ10), VITAMIN B COMPLEX (B COMPLEX [VITAMIN B COMPLEX]), ATORVASTATIN, GARLIC [ALLIUM SATIVUM] and FLAXSEED for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced MUSCLE TIGHTNESS (Muscle tension), VACCINATION SITE DISCOMFORT (Arm uncomfortable/arm didn't feel great), VACCINATION SITE WARMTH (Arm on fire), VACCINATION SITE RASH (Large big red circle about three inches/big circle on arm), VACCINATION SITE PAIN (Arm achy/arm tenderness) and VACCINATION SITE SWELLING (Arm inflammation). On 19-Mar-2021, the patient experienced MUSCULAR WEAKNESS (Arm weakness), VACCINATION SITE REACTION (Covid arm ring) and VACCINATION SITE ERYTHEMA (Redness). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, MUSCLE TIGHTNESS (Muscle tension), VACCINATION SITE DISCOMFORT (Arm uncomfortable/arm didn't feel great), MUSCULAR WEAKNESS (Arm weakness), VACCINATION SITE REACTION (Covid arm ring), VACCINATION SITE WARMTH (Arm on fire), VACCINATION SITE RASH (Large big red circle about three inches/big circle on arm), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE PAIN (Arm achy/arm tenderness) and VACCINATION SITE SWELLING (Arm inflammation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash, Vaccination site reaction, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Arm weakness; Covid arm ring; Redness; Arm achy/arm tenderness; Arm inflammation; Muscle tension; Arm uncomfortable/arm didn't feel great; Arm on fire; Large big red circle about three inches/big circle on arm; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TIGHTNESS (Muscle tension), VACCINATION SITE DISCOMFORT (Arm uncomfortable/arm didn't feel great), MUSCULAR WEAKNESS (Arm weakness), VACCINATION SITE REACTION (Covid arm ring) and VACCINATION SITE WARMTH (Arm on fire) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.  Concomitant products included COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), VITAMIN B [VITAMIN B NOS], VITAMIN C [ASCORBIC ACID], CALCIUM, UBIDECARENONE (QUNOL LIQUID COQ10), VITAMIN B COMPLEX (B COMPLEX [VITAMIN B COMPLEX]), ATORVASTATIN, GARLIC [ALLIUM SATIVUM] and FLAXSEED for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced MUSCLE TIGHTNESS (Muscle tension), VACCINATION SITE DISCOMFORT (Arm uncomfortable/arm didn't feel great), VACCINATION SITE WARMTH (Arm on fire), VACCINATION SITE RASH (Large big red circle about three inches/big circle on arm), VACCINATION SITE PAIN (Arm achy/arm tenderness) and VACCINATION SITE SWELLING (Arm inflammation). On 19-Mar-2021, the patient experienced MUSCULAR WEAKNESS (Arm weakness), VACCINATION SITE REACTION (Covid arm ring) and VACCINATION SITE ERYTHEMA (Redness). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, MUSCLE TIGHTNESS (Muscle tension), VACCINATION SITE DISCOMFORT (Arm uncomfortable/arm didn't feel great), MUSCULAR WEAKNESS (Arm weakness), VACCINATION SITE REACTION (Covid arm ring), VACCINATION SITE WARMTH (Arm on fire), VACCINATION SITE RASH (Large big red circle about three inches/big circle on arm), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE PAIN (Arm achy/arm tenderness) and VACCINATION SITE SWELLING (Arm inflammation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pyrexia
Clinical narrative: chills; 104 degree F temperature; feel as though their insides have been punched; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (feel as though their insides have been punched), CHILLS (chills) and PYREXIA (104 degree F temperature) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in 2021.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced PAIN (feel as though their insides have been punched) and PYREXIA (104 degree F temperature). On 18-Mar-2021 at 7:00 PM, the patient experienced CHILLS (chills). At the time of the report, PAIN (feel as though their insides have been punched), CHILLS (chills) and PYREXIA (104 degree F temperature) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, Body temperature: 104 (High) 104 degree F. On 19-Mar-2021, Body temperature: 101 (High) 101 degree F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported. No treatment medication was not reported. Patient stated that the effects of the vaccine was worse than the COVID-19 symptoms.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia
Clinical narrative: Loss of sensation of taste; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Loss of sensation of taste) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B/621A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced AGEUSIA (Loss of sensation of taste). At the time of the report, AGEUSIA (Loss of sensation of taste) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported No treatment medication was reported